Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes

[1]  N. Navin,et al.  Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing , 2014, Nature.

[2]  B. Faubert,et al.  Metabolic Heterogeneity in Human Lung Tumors , 2016, Cell.

[3]  J. Massagué,et al.  TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. , 2005, Cancer cell.

[4]  James L. Connolly,et al.  Role of the Surgical Pathologist in the Diagnosis and Management of the Cancer Patient , 2003 .

[5]  L. Cantley,et al.  Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. , 2015, Cancer research.

[6]  Xiao Han,et al.  Circulating Tumor DNA as Biomarkers for Cancer Detection , 2017, Genom. Proteom. Bioinform..

[7]  Charles Swanton,et al.  Translational Implications of Tumor Heterogeneity , 2015, Clinical Cancer Research.

[8]  Stephen Fox,et al.  The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE” , 2016, PLoS medicine.

[9]  P. Lønning,et al.  Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection , 2016, PLoS genetics.

[10]  Steven J. M. Jones,et al.  Spatial heterogeneity in medulloblastoma , 2017, Nature Genetics.

[11]  Garry P Nolan,et al.  Visualization and cellular hierarchy inference of single-cell data using SPADE , 2016, Nature Protocols.

[12]  T. Allen,et al.  Lung cancer genotype-based therapy and predictive biomarkers: present and future. , 2012, Archives of pathology & laboratory medicine.

[13]  Carlos Caldas,et al.  Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer , 2015, Nature Communications.

[14]  A. McKenna,et al.  Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. , 2014, Cancer cell.

[15]  Mariella G. Filbin,et al.  Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma , 2016, Nature.

[16]  M. Heymann,et al.  Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis , 2016, International journal of molecular sciences.

[17]  Huanming Yang,et al.  Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm , 2012, Cell.

[18]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[19]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[20]  J. Buhmann,et al.  Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.

[21]  P. A. Futreal,et al.  Emerging patterns of somatic mutations in cancer , 2013, Nature Reviews Genetics.

[22]  C. Sander,et al.  Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy , 2014, Clinical Cancer Research.

[23]  Robyn L. Ward,et al.  The role of BRCA mutation testing in determining breast cancer therapy , 2010, Nature Reviews Clinical Oncology.

[24]  Obi L. Griffith,et al.  Convergent loss of PTEN leads to clinical resistance to a PI3Kα inhibitor , 2014, Nature.

[25]  Fabio Del Ben,et al.  Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack , 2016, International journal of molecular sciences.

[26]  Ashwini Naik,et al.  Phylogenetic ctDNA analysis depicts early stage lung cancer evolution , 2017, Nature.

[27]  Francine E. Garrett-Bakelman,et al.  Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia , 2016, Nature Medicine.

[28]  Uri Alon,et al.  Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor , 2017, BMC Systems Biology.

[29]  Fiona Ginty,et al.  Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism. , 2016, JCI insight.

[30]  Yi-long Wu,et al.  Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer. , 2017, The oncologist.

[31]  A. Levan.  CHROMOSOMES IN CANCER TISSUE , 1955, Annals of the New York Academy of Sciences.

[32]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[33]  C. T. Stayton.  Is convergence surprising? An examination of the frequency of convergence in simulated datasets. , 2008, Journal of theoretical biology.

[34]  R. Houot,et al.  Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy? , 2016, European journal of cancer.

[35]  G. Getz,et al.  Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition , 2016, Nature Medicine.

[36]  Michael R. Padgen,et al.  Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments , 2017, Nature Cell Biology.

[37]  Nicolai J. Birkbak,et al.  Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.

[38]  Yongjun Zhao,et al.  Clonal evolution of high‐grade serous ovarian carcinoma from primary to recurrent disease , 2013, The Journal of pathology.

[39]  Mark J. Ratain,et al.  Tumour heterogeneity in the clinic , 2013, Nature.

[40]  Huanming Yang,et al.  Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.

[41]  P. Delvenne,et al.  Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies , 2014, Hepatology.

[42]  Ker-Chau Li,et al.  Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling , 2014, Nature Communications.

[43]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[44]  N. Tunariu,et al.  Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration , 2015, Clinical Cancer Research.

[45]  N. Lennon,et al.  Technological considerations for genome-guided diagnosis and management of cancer , 2016, Genome Medicine.

[46]  H. Woo,et al.  Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis , 2011, Proceedings of the National Academy of Sciences.

[47]  M. Stratton,et al.  Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing , 2008, Proceedings of the National Academy of Sciences.

[48]  Nicolai J. Birkbak,et al.  Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.

[49]  Jeong Eon Lee,et al.  Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer , 2017, Nature Communications.

[50]  William Pao,et al.  The Impact of Microenvironmental Heterogeneity on the Evolution of Drug Resistance in Cancer Cells , 2015, Cancer informatics.

[51]  N. Navin,et al.  The first five years of single-cell cancer genomics and beyond , 2015, Genome research.

[52]  Xin Xu,et al.  Spatial intratumor heterogeneity of genetic, epigenetic alterations and temporal clonal evolution in esophageal squamous cell carcinoma , 2016, Nature Genetics.

[53]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[54]  Nicolai J. Birkbak,et al.  Clonal status of actionable driver events and the timing of mutational processes in cancer evolution , 2015, Science Translational Medicine.

[55]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[56]  Sabine Riethdorf,et al.  Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells. , 2016, Clinical chemistry.

[57]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[58]  R. Arceci.  Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .

[59]  G. Dontu,et al.  Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. , 2011, Cancer research.

[60]  A. Viale,et al.  Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases , 2017, Clinical Cancer Research.

[61]  Ben S. Wittner,et al.  A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.

[62]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[63]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[64]  Amos Tanay,et al.  Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. , 2014, Cell reports.

[65]  C. Swanton.  Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.

[66]  Guo-Cheng Yuan,et al.  Single-Cell Analysis in Cancer Genomics. , 2015, Trends in genetics : TIG.

[67]  Charles M Perou,et al.  Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models , 2014, Clinical Cancer Research.

[68]  R. Schilsky.  Clinical implications of tumor heterogeneity. , 1987, Haematology and blood transfusion.

[69]  H. Aburatani,et al.  Genetic and epigenetic stability of oligodendrogliomas at recurrence , 2017, Acta neuropathologica communications.

[70]  Z. Cai,et al.  Single-cell exome sequencing identifies mutations in KCP, LOC440040, and LOC440563 as drivers in renal cell carcinoma stem cells , 2016, Cell Research.

[71]  M. Berger,et al.  Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[72]  Xuemei Lu,et al.  Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution , 2015, Proceedings of the National Academy of Sciences.

[73]  Faraz Hach,et al.  Spatial genomic heterogeneity within localized, multifocal prostate cancer , 2015, Nature Genetics.

[74]  Arne Traulsen,et al.  Detecting truly clonal alterations from multi-region profiling of tumours , 2017, Scientific Reports.

[75]  Xiaoping Liu,et al.  Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma. , 2017, Cancer research.

[76]  Joshy George,et al.  Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.

[77]  J. Hsieh,et al.  A river model to map convergent cancer evolution and guide therapy in RCC , 2015, Nature Reviews Urology.

[78]  Sydney M. Shaffer,et al.  Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance , 2017, Nature.

[79]  Liju Yang,et al.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. , 2014, Assay and drug development technologies.

[80]  N. Schork,et al.  The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? , 2011, Personalized medicine.

[81]  Florian Markowetz,et al.  OncoNEM: inferring tumor evolution from single-cell sequencing data , 2016, Genome Biology.

[82]  N. Ahmed,et al.  Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells , 2016, Scientific Reports.

[83]  Xionglei He,et al.  The Convergent Cancer Evolution toward a Single Cellular Destination. , 2016, Molecular biology and evolution.

[84]  Xionglei He,et al.  The reverse evolution from multicellularity to unicellularity during carcinogenesis , 2015, Nature Communications.

[85]  E. Mroz,et al.  Intra-tumor Genetic Heterogeneity and Mortality in Head and Neck Cancer: Analysis of Data from The Cancer Genome Atlas , 2015, PLoS medicine.

[86]  W. Park,et al.  Genomic Characterization and Comparison of Multi-Regional and Pooled Tumor Biopsy Specimens , 2016, PloS one.

[87]  Marc J. Williams,et al.  Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.

[88]  James D. Brenton,et al.  Liquid biopsies come of age: towards implementation of circulating tumour DNA , 2017, Nature Reviews Cancer.

[89]  Ash A. Alizadeh,et al.  Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients , 2016, Nature Communications.

[90]  Ö. Winge.  Zytologische Untersuchungen über die Natur maligner Tumoren , 1927, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[91]  T. Vincent,et al.  Divergent and convergent evolution in metastases suggest treatment strategies based on specific metastatic sites , 2015, Evolution, medicine, and public health.

[92]  K. Lim,et al.  Clinical significance of heterogeneity in response to retreatment with epidermal growth factor receptor tyrosine kinase inhibitors in patients with lung cancer acquiring secondary resistance to the drug. , 2014, Clinical lung cancer.

[93]  Kathleen R. Cho,et al.  Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. , 2011, The Journal of clinical investigation.

[94]  Akhilesh Pandey,et al.  Heterogeneity of Pancreatic Cancer Metastases in a Single Patient Revealed by Quantitative Proteomics* , 2014, Molecular & Cellular Proteomics.

[95]  A. Azmi,et al.  Immune evasion in cancer: Mechanistic basis and therapeutic strategies. , 2015, Seminars in cancer biology.

[96]  Daniel V.T. Catenacci,et al.  Next‐generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity , 2014, Molecular oncology.

[97]  C. Mackall,et al.  Going back to class I: MHC and immunotherapies for childhood cancer , 2015, Pediatric blood & cancer.

[98]  Sean C. Bendall,et al.  Extracting a Cellular Hierarchy from High-dimensional Cytometry Data with SPADE , 2011, Nature Biotechnology.

[99]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[100]  Ashwini Bhasi,et al.  Intra-tumor Genetic Heterogeneity in Rectal Cancer , 2015, Laboratory Investigation.

[101]  Evis Sala,et al.  Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis , 2015, PLoS medicine.

[102]  A. Jekunen,et al.  Clinicians’ Expectations for Gene-Driven Cancer Therapy , 2014, Clinical Medicine Insights. Oncology.

[103]  Guy S. Salvesen,et al.  SnapShot: Caspases , 2011, Cell.

[104]  T. Speed,et al.  Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE" , 2017, PLoS medicine.

[105]  Song Wu,et al.  Single-cell analyses of transcriptional heterogeneity in squamous cell carcinoma of urinary bladder , 2016, Oncotarget.

[106]  R. Buckanovich,et al.  Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop , 2016, Oncotarget.

[107]  Jeffrey T Leek,et al.  Evolution of cellular morpho-phenotypes in cancer metastasis , 2015, Scientific Reports.